In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 4.1 below 10x Genomics Inc average.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Quick Ratio than 10x Genomics Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 665 to 848.

Explain Quick Ratio?
How much Cash & cash equivalents TXG�s has?
What are TXG�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TXG/financial-strength

https://api.csimarket.com/api/v1/companies/TXG/fundamentals

https://api.csimarket.com/api/v1/companies/TXG/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

TXG Quick Ratio	(Sep 30 2026) Q3	(Jun 30 2026) Q2	(Mar 31 2026) Q1	(Dec 31 2025) Q4	(Sep 30 2025) Q3
Y / Y Current Liabilities Change	20.05 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	19.42 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	4.1	Subscribe	Subscribe	Subscribe	Subscribe
TXG's Total Ranking	# 848	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	18.45 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	4.29 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 6
Healthcare Sector	# 321
Overall Market	# 848

Quick Ratio Statistics
High	Average	Low
15.72	6.19	2.78
(Sep 30 2019)		(Jun 30 2020)

Financial Statements
10x Genomics Inc 's Current Liabilities	$ 140 Millions	Visit TXG's Balance sheet
10x Genomics Inc 's Cash & cash equivalent	$ 576 Millions	Visit TXG's Balance sheet
Source of TXG's Sales		Visit TXG's Sales by Geography

Cumulative 10x Genomics Inc 's Quick Ratio

TXG's Quick Ratio for the trailling 12 Months

TXG Quick Ratio	(Sep 30 2026) 12 Months	(Jun 30 2026) 12 Months	(Mar 31 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 30 2025) 12 Months
Y / Y Current Liabilities TTM Growth	31.64 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	25.23 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	4.17	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3680	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	4.67 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	4.46 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to TXG Financial Strength Comparisons >> Go to Compare TXG Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the increase in Current Liabilities in the Q3 2026 to $140.37 millions, cumulative Quick Ratio remained unchanged at 4.17 above the TXG average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 21 other companies have achieved higher Quick Ratio than 10x Genomics Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 2727 to 3680.

Explain Quick Ratio?
How much Cash & cash equivalents TXG�s has?
What are TXG�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Laboratory Analytical Instruments Industry	# 22
Healthcare Sector	# 869
Within the Market	# 3680

trailing twelve months Quick Ratio Statistics
High	Average	Low
6.36	3.84	2.17
(Mar 31 2020)		(Mar 31 2023)

Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Laboratory Analytical Instruments Industry	Quick Ratio	Sep 30 2026 MRQ Cash & cash equivalent	Sep 30 2026 MRQ Current Liabilities
Alamar Biosciences Inc	6.77	$ 226.585 Millions	$ 33.482 Millions
Standard Biotools Inc	5.24	$ 267.487 Millions	$ 51.021 Millions
10x Genomics Inc	4.10	$ 575.725 Millions	$ 140.370 Millions
Pacific Biosciences Of California Inc	3.01	$ 200.217 Millions	$ 66.593 Millions
Seer Inc	2.95	$ 29.316 Millions	$ 9.942 Millions
Cytek Biosciences Inc	2.58	$ 255.899 Millions	$ 99.179 Millions
Quanterix Corporation	1.51	$ 77.359 Millions	$ 51.130 Millions
Nautilus Biotechnology Inc	1.07	$ 10.467 Millions	$ 9.758 Millions
Precipio inc	0.90	$ 3.576 Millions	$ 3.985 Millions
Bio rad Laboratories Inc	0.86	$ 837.100 Millions	$ 969.100 Millions

Date modified: 2026-11-07T13:24:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.